Literature DB >> 25567180

New strategies immediately needed for molecular marker reporting in colorectal cancer.

Daniel A Sussman1, Monique N Hernandez1, Stacey L Tannenbaum1, Judith M Bonner1, L A McClure1, D J Lee1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25567180     DOI： 10.1038/ajg.2014.360

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

1.  Enhancing central cancer registry treatment data using physician medical claims: a Florida pilot project.

Authors:  Monique N Hernandez; Jill A MacKinnon; Lynne Penberthy; Judy Bonner; Youjie X Huang
Journal:  J Registry Manag       Date:  2014

2.  Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy.

Authors:  Frank A Sinicrope; Michelle R Mahoney; Thomas C Smyrk; Stephen N Thibodeau; Robert S Warren; Monica M Bertagnolli; Garth D Nelson; Richard M Goldberg; Daniel J Sargent; Steven R Alberts
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

3.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.

Authors:  Francis M Giardiello; John I Allen; Jennifer E Axilbund; C Richard Boland; Carol A Burke; Randall W Burt; James M Church; Jason A Dominitz; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David A Lieberman; Douglas J Robertson; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2014-07-22       Impact factor: 10.864

4.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.